CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation

Krzysztof Szade1, Ewa Zuba-Surma, Andrzej J Rutkowski

  • 1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

Insights

Researchers isolated a novel multipotent stem cell population from bone marrow. These CD45(-)CD14(+)CD34(+) cells can be expanded long-term and differentiate into endothelial and neuronal lineages.

Area of Science:

  • Stem cell biology
  • Hematology
  • Regenerative medicine

Background:

  • Mesenchymal stem cells (MSCs) derived from bone marrow are a heterogeneous population.
  • Expansion of primitive MSC subsets remains challenging.
  • Understanding MSC heterogeneity is crucial for therapeutic applications.

Purpose of the Study:

  • To optimize a protocol for propagating a specific low-adherent subfraction of bone marrow-derived cells.
  • To characterize the phenotype and multipotency of the expanded cell population.
  • To assess the differentiation potential and functional properties of these cells.

Main Methods:

  • Optimized culture protocol for low-adherent bone marrow cells.
  • Flow cytometry analysis for cell surface markers (CD45, CD14, CD34, MSC markers).
  • In vitro differentiation assays towards endothelial and neuronal lineages.
  • Assessment of angiogenic marker expression and functional endothelium properties.
  • In vitro sphere formation assay.

Main Results:

  • Successfully established long-term expansion of a CD45(-)CD14(+)CD34(+) cell population expressing common MSC markers.
  • Expanded cells demonstrated multipotency, differentiating into endothelial cells with angiogenic properties and neuronal cells.
  • These cells formed characteristic cellular spheres in vitro, indicative of primitive stem cell features.
  • The isolated subpopulation maintained its potential during long-term culture.

Conclusions:

  • A novel multipotent subpopulation of bone marrow-derived cells (CD45(-)CD14(+)CD34(+)) was isolated and characterized.
  • This subpopulation can be expanded long-term while retaining multipotency and primitive stem cell characteristics.
  • These findings offer potential for new therapeutic strategies in regenerative medicine and cell-based therapies.

Related Concept Videos